Sign Up for Free!

Continue Analyzing the page and more.

Continue with Google

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Upgrade to Pro
Home Daily Intelligence Tracker
    • Plans Blog Contact
    CANNABIS SUISSE CORP. logo
    CSUI

    CANNABIS SUISSE CORP.

    MaveScore 27 Low model confidence
    Last Price US$0.00 As of Jun 15, 2026
    Market Cap US$346300.0 Company size context
    7D Performance 2.08% Past 7 days
    1Y Performance -77.73% Past 12 months
    Model Rating
    Historical model output for research review

    Fundamental data date

    Feb 28, 2026

    108 days old

    Market price date

    Jun 15, 2026

    1 day old

    Coverage

    16/16

    No missing model inputs

    Data quality

    Excellent

    Current stored snapshot

    Transparent research score

    Why the model scores this stock

    MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

    MaveScore 27 Low confidence

    Stored data quality

    Freshness and coverage checks

    Latest stored fundamentals and price inputs are recent enough for normal research review.

    16/16 Current stored snapshot

    Quality

    Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

    8/35 Weak

    Financial Strength

    Financial strength rewards durable profitability, margins, and positive free cash flow.

    6/25 Weak

    Valuation Support

    Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

    5/15 Weak

    Momentum

    Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

    8/15 Mixed

    Shareholder Alignment

    Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

    0/10 Weak

    Positive model output

    More live company inputs are needed before positive research signals can be surfaced.

    Research risks to review

    • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
    • Financial strength rewards durable profitability, margins, and positive free cash flow.
    • Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

    MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting.

    Overview Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Ratio
    Dashboard Funda..tals Deep..lue Prediction Screener Map

    CANNABIS SUISSE CORP. Overview

    Industry: Drug Manufacturers Specialty & Generic

    Sector: Healthcare

    Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company's products include flavored broad-spectrum CBD oils and CBD isolate tinctures with no THC. It sells its products through Swiss4Life, a retail brand for online selling, as well as a network of retailers. The company also provides Cannabis Life, a mobile application based on an AI-chatbot that will have access to the most up-to-date information and find out data about companies and brands that sell seeds, cannabis types, etc. In addition, it offers health-related supplements, and retail branded cigarettes. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. is based in Jacksonville, Florida.

    CANNABIS SUISSE CORP. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

    Score

    Price History & Performance

    Review CANNABIS SUISSE CORP. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

    Recent News



    CANNABIS SUISSE CORP. Competitors

    CANNABIS SUISSE CORP. operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

    Earnings Per Share

    EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

    Continue the analysis

    Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

    View plans
    Ticker Image

    CANNABIS SUISSE CORP.

    US$0.00

    US$346300.0

    2.08%

    -77.73%